A Young Man with Myocardial Infarction due to Trenbolone Acetate; a Case Report
Archives of Academic Emergency Medicine,
Vol. 2 No. 1 (2014),
1 Bahman 2014
,
Page 43-45
https://doi.org/10.22037/aaem.v2i1.22
Abstract
Over the four decades, a significant decrease has been observed in age-related mortality caused by cardiovascular disease. People in developing countries suffer from CAD at a relatively younger age and about half of MI occurs under the age of fifty years. Abuse of anabolic steroids is one of the less common causes of atherosclerosis. In this report, a 23-year-old body builder male referred to emergency department (ED) with myocardial infarction (MI) following chronic Trenbolone acetate consumption. It seems that a comprehensive history of steroid consumption in young patients referred to ED with the chief complaint of chest pain or its equivalents is necessary in adjunct to other cardiac risk factors.- Chest pain
- anabolic agents
- myocardial infarction
- young adult
How to Cite
References
Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. The Lancet. 1997; 349(9061):1269-76.
Marx JA, Hockberger RS, Walls RM, Adams GA. Concepts and clinical practice. Rosen's emergency medicine. 8ed. Philadelp- hia, PA: Elsevier Saunders; 2014. p. 997-1033.
Enas EA, Senthilkumar A. Coronary artery disease in Asian Indians: an update and review. Coron Artery Dis. 2005;3:21-57.
Maron BJ. The young competitive athlete with cardio- vascular abnormalities: causes of sudden death, detection by preparticipation screening, and standards for disqualification. Card Electrophysiol rev. 2002;6(1):100-3.
Balagopal PB, de Ferranti SD, Cook S, et al. Nontraditional risk factors and biomarkers for cardiovascular disease: me-chanistic, research, and clinical considerations for youth a sci-entific statement from the American Heart Association. Circulation. 2011;123(23):2749-69.
Libby P, Theroux P. Pathophysiology of coronary artery disease. Circulation. 2005;111(25):3481-8.
Kam P, Yarrow M. Anabolic steroid abuse: physiological and anaesthetic considerations. Anaesthesia. 2005;60(7):685-92.
Korkia P. Use of anabolic steroids has been reported by 9% of men attending gymnasiums. Brit Med J. 1996;313(7063): 1009-14.
Buckley WE, Yesalis III CE, Friedl KE, Anderson WA, Streit AL, Wright JE. Estimated prevalence of anabolic steroid use among male high school seniors. JAMA. 1988;260(23):3441-5.
Dawson R. Drugs in sport-the role of the physician. J Endocrinol. 2001;170(1):55-61.
Dickerman RD, McConathy WJ, Zachariah NY. Testoster-one, sex hormone-binding globulin, lipoproteins, and vascular disease risk. J Cardiovasc Risk. 1997;4(5-6):363-6.
Glazer G. Atherogenic effects of anabolic steroids on serum lipid levels: a literature review. Arch Intern Med. 1991;151 (10):1925-31.
Hartgens F, Rietjens G, Keizer H, Kuipers H, Wolffenbuttel B. Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a). Brit J Sports Med. 2004;38(3):253-9.
Rockhold R. Cardiovascular toxicity of anabolic steroids. Annu Rev Pharmacol Toxicol. 1993;33(1):497-520.
Pärssinen M, Seppälä T. Steroid use and long-term health risks in former athletes. Sports Med. 2002;32(2):83-94.
Zarkawi M, Galbraith H, Hutchinson J. The action of trenb-olone acetate, a synthetic anabolic steroid, on ovarian function in the guineapig. Lab Anim. 1991;25(2):117-21.
Skarberg K, Nyberg F, Engstrom I. Multisubstance use as a feature of addiction to anabolic-androgenic steroids. Eur Addict Res. 2009;15(2):99-106.
Wilson VS, Lambright C, Ostby J, Gray LE, Jr. In vitro and in vivo effects of 17beta-trenbolone: a feedlot effluent contamin-ant. Toxicol Sci. 2002;70(2):202-11.
- Abstract Viewed: 499 times
- PDF Downloaded: 2924 times
Download Statastics
Make a Submission
SJR
COPE
